Skip to main content
Premium Trial:

Request an Annual Quote

Ayers is Genomica's New CEO, Marr Still Presides

Premium

BOULDER, Colo.--Teresa Ayers is the new CEO at Genomica, a pharmacogenomics software company. She will work together with Thomas Marr, who continues as president, chief scientist, and director of Genomica. Ayers had been president and chief executive officer of BioStar, a manufacturer and marketer of in vitro human diagnostic tests. Before that, she was chief financial officer of CytRx, a publicly traded biotech company; Biopool, a publicly traded human diagnostic business; and Plasti-Line, a publicly traded signage firm. Genomica was founded by Marr in 1996 as a way to market the tools he and his team developed at Cold Spring Harbor Laboratory in New York.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.